Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Ping Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6707-8636; OpenAlex author ID A5100400291. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancer. Co-author DOI 10.1038/s41467-024-47242-3↗
  2. Association between single-nucleotide polymorphisms of OGG1 gene and pancreatic cancer risk in Chinese Han population. Last author DOI 10.1007/s13277-013-1111-6↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ching-Fei Li · 1 shared paper, 2024 · strength 0.14
  2. Jianhua Ling · 1 shared paper, 2024 · strength 0.14
  3. Huamin Wang · 1 shared paper, 2024 · strength 0.14
  4. Ya’an Kang · 1 shared paper, 2024 · strength 0.14
  5. Qian Huang · 1 shared paper, 2024 · strength 0.14
  6. Kenei Furukawa · 1 shared paper, 2024 · strength 0.14
  7. Lu Yu · 1 shared paper, 2024 · strength 0.14
  8. Jun Zhao · 1 shared paper, 2024 · strength 0.14
  9. Wenjuan Yin · 1 shared paper, 2024 · strength 0.14
  10. Jun Yao · 1 shared paper, 2024 · strength 0.14
  11. Jie Fu · 1 shared paper, 2024 · strength 0.14
  12. Paul J. Chiao · 1 shared paper, 2024 · strength 0.14
  13. Jason B. Fleming · 1 shared paper, 2024 · strength 0.14
  14. Anirban Maitra · 1 shared paper, 2024 · strength 0.14
  15. Mien‐Chie Hung · 1 shared paper, 2024 · strength 0.14
  16. Peng Huang · 1 shared paper, 2024 · strength 0.14
  17. Hongxu Chen · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.